At CPC Scientific, we appreciate the interest and inquiries from the media regarding our business, services, and capabilities. Feel free to utilize the resources provided on this page or reach out to our media relations team for specific inquiries. We’ll ensure that you are connected with the relevant business leader or subject matter expert.
Featured CPC Scientific News
News from CPC Scientific
SAN JOSE, CA., June 25, 2020 /CPCNewswire/ — CPC Scientific Inc., a San Jose based CDMO with GMP manufacturing facilities in Hangzhou, is pleased to announce that […]
On 28 May 2020, the European Medicines Agency (EMA), via its Committee for Medicinal Products for Human Use (CHMP), adopted a positive opinion of Hepcludex. This drug […]
To Our Valued Customers,
With the growing concern of the Coronavirus Disease 2019 (COVID-19) outbreak, CPC Scientific wants to assure you that our peptide manufacturing facilities are fully […]
San Jose, CA and New York, NY – CPC Scientific Inc., a CDMO specializing in synthetic peptide manufacturing, will host at DCAT Week® for a 5th consecutive […]
SUNNYVALE, US. and Hangzhou, China, June 24th, 2019 /CPCNewswire/ — CPC Scientific Inc. and its affiliate Chinese Peptide Company, a public Hangzhou-based CDMO (Stock Symbol: 002390) is […]
to Manufacture Neoantigen Peptides for the PANDA (Personalized and Adaptive) Cancer Vaccine Program.
SUNNYVALE, California, Feb. 19, 2019 – CPC Scientific Inc., a leading global CDMO specializing in […]